When should one consider tyrosine kinase inhibitor therapy for medullary thyroid cancer? 153
0 Views
administrator
07/10/23
Originally presented at the 23rd International Thyroid Cancer Survivors’ Virtual Conference held October 23-25, 2020.
When should one consider tyrosine kinase inhibitor therapy for medullary thyroid cancer? Robert F. Gagel, MD, Endocrinologist, and Mark E. Zafereo, MD, Head and Neck Surgeon.
-
Category
Show more
Facebook Comments
No comments found